MediWound Ltd.
MDWD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $20,222 | $18,686 | $26,496 | $23,763 |
| % Growth | 8.2% | -29.5% | 11.5% | – |
| Cost of Goods Sold | $18,441 | $15,739 | $14,176 | $15,627 |
| Gross Profit | $1,781 | $2,947 | $12,320 | $8,136 |
| % Margin | 8.8% | 15.8% | 46.5% | 34.2% |
| R&D Expenses | $8,254 | $7,071 | $9,610 | $9,904 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $12,910 | $11,377 | $10,371 | $9,453 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21,164 | $18,448 | $19,981 | $19,357 |
| Operating Income | -$19,383 | -$15,501 | -$7,661 | -$11,221 |
| % Margin | -95.9% | -83% | -28.9% | -47.2% |
| Other Income/Exp. Net | -$10,780 | $8,970 | -$11,860 | -$2,303 |
| Pre-Tax Income | -$30,163 | -$6,531 | -$19,521 | -$13,524 |
| Tax Expense | $61 | $185 | $78 | $27 |
| Net Income | -$30,224 | -$6,716 | -$19,599 | -$13,551 |
| % Margin | -149.5% | -35.9% | -74% | -57% |
| EPS | -3.03 | -0.75 | -3.93 | -3.48 |
| % Growth | -304% | 80.9% | -12.9% | – |
| EPS Diluted | -3.03 | -0.75 | -3.93 | -3.48 |
| Weighted Avg Shares Out | 9,960 | 9,013 | 4,987 | 3,892 |
| Weighted Avg Shares Out Dil | 9,960 | 9,013 | 4,987 | 3,892 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,048 | $2,341 | $270 | $11 |
| Interest Expense | $561 | $335 | $162 | $167 |
| Depreciation & Amortization | $1,483 | $1,303 | $1,271 | $1,238 |
| EBITDA | -$28,119 | -$4,893 | -$18,088 | -$12,119 |
| % Margin | -139.1% | -26.2% | -68.3% | -51% |